A Randomized, Open-Label, Multicenter Study of Liposomal Amikacin for Inhalation (LAI) in Adult patients with nontuberculous Mycobacterial (NTM) Lung Infections caused by Mycobacterium aviumcomplex (MAC) that are refractory to treatment

Principal Investigator

CONTACT INFORMATION

Primary Contact:
Susan Jacobs
(650) 725-8083